share_log

C4 Therapeutics' Cash, Cash Equivalents and Marketable Securities Total $299.2M As Of March 31, 2024; Expected To Provide Runway Into 2027

C4 Therapeutics' Cash, Cash Equivalents and Marketable Securities Total $299.2M As Of March 31, 2024; Expected To Provide Runway Into 2027

截至2024年3月31日,C4 Therapeutics的現金、現金等價物和有價證券總額爲2.992億美元;預計將爲2027年提供跑道
Benzinga ·  05/08 07:26

C4 Therapeutics' Cash, Cash Equivalents and Marketable Securities Total $299.2M As Of March 31, 2024; Expected To Provide Runway Into 2027

截至2024年3月31日,C4 Therapeutics的現金、現金等價物和有價證券總額爲2.992億美元;預計將爲2027年提供跑道

声明:本內容僅用作提供資訊及教育之目的,不構成對任何特定投資或投資策略的推薦或認可。 更多信息
    搶先評論